These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19724898)

  • 1. Effect of polymorphisms of IL-17A, -17F and MIF genes on CpG island hyper-methylation (CIHM) in the human gastric mucosa.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
    Int J Mol Med; 2009 Oct; 24(4):563-9. PubMed ID: 19724898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between IL-17A, -17F and MIF polymorphisms predispose to CpG island hyper-methylation in gastric cancer.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
    Int J Mol Med; 2010 Mar; 25(3):471-7. PubMed ID: 20127054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of polymorphisms of IL-1β and TNF-α genes on CpG island hyper methylation (CIHM) in the nonneoplastic gastric mucosa.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Hirata I; Arisawa T
    Mol Carcinog; 2011 Nov; 50(11):835-45. PubMed ID: 21400614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa.
    Takano H; Shibata T; Nakamura M; Sakurai N; Hayashi T; Ota M; Nomura-Horita T; Hayashi R; Shimasaki T; Otsuka T; Tahara T; Arisawa T
    BMC Med Genet; 2020 Oct; 21(1):205. PubMed ID: 33066747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased number of CpG island hypermethylation in tumor suppressor genes of non-neoplastic gastric mucosa correlates with higher risk of gastric cancer.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
    Digestion; 2010; 82(1):27-36. PubMed ID: 20150736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of MIF polymorphisms on CpG island hyper-methylation of CDKN2A in the patients with ulcerative colitis.
    Sakurai N; Shibata T; Nakamura M; Takano H; Hayashi T; Ota M; Nomura-Horita T; Hayashi R; Shimasaki T; Ostuka T; Tahara T; Arisawa T
    BMC Med Genet; 2020 Oct; 21(1):201. PubMed ID: 33046033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic nonsteroidal anti-inflammatory drug (NSAID) use suppresses multiple CpG islands hyper methylation (CIHM) of tumor suppressor genes in the human gastric mucosa.
    Tahara T; Shibata T; Yamashita H; Nakamura M; Yoshioka D; Okubo M; Hirata I; Arisawa T
    Cancer Sci; 2009 Jul; 100(7):1192-7. PubMed ID: 19432886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cyclin D1 polymorphism with CpG island promoter methylation status of tumor suppressor genes in gastric cancer.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
    Dig Dis Sci; 2010 Dec; 55(12):3449-57. PubMed ID: 20397048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between polymorphisms in the XRCC1 and GST genes, and CpG island methylation status in colonic mucosa in ulcerative colitis.
    Tahara T; Shibata T; Nakamura M; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Hirata I; Arisawa T
    Virchows Arch; 2011 Feb; 458(2):205-11. PubMed ID: 21234761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk.
    Kaise M; Yamasaki T; Yonezawa J; Miwa J; Ohta Y; Tajiri H
    Helicobacter; 2008 Feb; 13(1):35-41. PubMed ID: 18205664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of DNA repair and xenobiotic genes predispose to CpG island methylation in non-neoplastic gastric mucosa.
    Tahara T; Shibata T; Nakamura M; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Ishizuka T; Hirata I; Arisawa T
    Helicobacter; 2011 Apr; 16(2):99-106. PubMed ID: 21435086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of molecules associated with inflammation and immune response in Japanese subjects with functional dyspepsia.
    Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
    Int J Mol Med; 2007 Nov; 20(5):717-23. PubMed ID: 17912466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer.
    Tahara T; Shibata T; Arisawa T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I
    Anticancer Res; 2010 Jan; 30(1):239-44. PubMed ID: 20150642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis.
    Shibata T; Tahara T; Hirata I; Arisawa T
    Hum Immunol; 2009 Jul; 70(7):547-51. PubMed ID: 19414056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis.
    Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Nakamura M; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
    J Clin Immunol; 2008 Jan; 28(1):44-9. PubMed ID: 17828618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium.
    Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
    Oncol Rep; 2008 Jan; 19(1):211-6. PubMed ID: 18097597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of catechol-O-methyltransferase (COMT) gene polymorphism on promoter methylation status in gastric mucosa.
    Tahara T; Shibata T; Arisawa T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nagasaka M; Iwata M; Takahama K; Watanabe M; Hirata I
    Anticancer Res; 2009 Jul; 29(7):2857-61. PubMed ID: 19596974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTHFR 677T carrier influences the methylation status of H. pylori-infected gastric mucosa in older subjects.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Takahama K; Watanabe M; Hirata I; Arisawa T
    Dig Dis Sci; 2009 Nov; 54(11):2391-8. PubMed ID: 19082889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer.
    Wu X; Zeng Z; Chen B; Yu J; Xue L; Hao Y; Chen M; Sung JJ; Hu P
    Int J Cancer; 2010 Jul; 127(1):86-92. PubMed ID: 19904747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.